|
|
Article: Micell Forges Strategic Agreement to Develop Advanced Drug-Eluting Stents and Balloons.
- Article from:
- PR Newswire
- Article date:
- January 12, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Company In-licenses State-of-the-art CE-Marked Cobalt-Chromium Coronary Stent
Forms Alliance to Jointly Develop Drug Eluting Balloon Products
RALEIGH, N.C., Jan. 12 /PRNewswire/ -- Micell Technologies announced today that that the company entered into a strategic agreement with Maxcor Inc., the newly incorporated subsidiary of Opto Circuits (OCI) Ltd., by which Micell Technologies has obtained the rights to Maxcor's Genius MAGIC Cobalt Chromium Coronary Stent System for the purpose of developing and marketing Drug-Eluting Stents (DES) based on Micell's prop coating technology. The state-of-the-art stent and delivery system was developed and is marketed ...